We analyze noise-free headlines and recent hype associated with HSBC Midcap Equity Dir Div which may create opportunities for some arbitrage if properly timed. With HSBC Midcap hype-based prediction module you can estimate the value of HSBC Midcap Equity Dir Div from the prospective of HSBC Midcap response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on HSBC Midcap over a specific investment horizon. Additionally see Investing Opportunities.
|Horizon||30 Days Login to change|
HSBC Midcap After-Hype Price Density Analysis
Next price density
HSBC Midcap Estimiated After-Hype Price Volatility
December 15, 2018
HSBC Midcap is Unknown risk asset. Analysis and calculation of next after-hype price of HSBC Midcap Equity is based on 2 months time horizon.
HSBC Midcap Next Price Analysis
|Daily Expected return||Period Volatility||Hype elasticity||Related hype elasticity||Average news density||Related news density||Next Expected Hype|
|0.00%||0.00%||0.00%||0.00%||1 Events / Month||0 Events / Month||Very soon|
|Latest traded price||Expected after-news price||Potential return on next major news||Average after-hype volatility|
HSBC Midcap Hype TimelineHSBC Midcap Equity Dir Div is currently traded for 20.90on Bombay Stock Exchange of India. This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. HSBC Midcap Equity Dir Div is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is currently at 0.0%. The volatility of relative hype elasticity to HSBC Midcap is about 0.0%%. The volatility of related hype on HSBC Midcap is about 0.0% with expected price after next announcement by competition of 20.9. The company had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be very soon. Additionally see Investing Opportunities.
|Purchase by James Robinson of 5237 shares of Nymox PharmaceuticalDecember 14, 2018 for James Robinson|
|Exercise or conversion by Anthony Tiscornia of 261 shares of Coupa Software subject to Rule 16b 3December 14, 2018 for Anthony Tiscornia|
|View All Premium Stories|
Investors are also interested in